Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Doctor training aims to cut risky pill overload in seniors

NCT ID NCT06470308

First seen Feb 18, 2026 · Last updated Jun 23, 2026 · Updated 11 times

Summary

This study tests whether giving general practitioners special training on how to safely reduce medications (deprescribing) leads to fewer unnecessary prescriptions for older adults. About 200 patients aged 65+ who take at least 5 medications are taking part. The goal is to see if the training helps doctors lower the number of risky or unneeded drugs.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POLYPHARMACY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Primary Care Facilities

    Heraklion, Heraklion, Crete, 71303, Greece

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

educational intervention for general practitioners on deprescribing

What this could lead to

If successful, this could show that training doctors to review and reduce medications improves safety for older adults on multiple drugs.

What could go wrong

This is a small, early-stage study in one country (Greece). Results may not apply elsewhere, and the intervention may not lead to meaningful changes in prescribing.

Conditions

The condition(s) this trial relates to.

Frailty Prescription Drug Overuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.